These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7590419)

  • 1. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
    Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
    Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas].
    Mirouze J; Selam JL; Pham TC; Mendoza E
    Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
    Behme MT; Dupre J; Stiller CR
    Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting remission in type I diabetes.
    Pelkonen R; Aro A
    Ann Clin Res; 1984; 16(2):94-7. PubMed ID: 6380392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J; Selam JL; Pham TC; Orsetti A
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
    Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
    C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
    Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG
    Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of short-term administration of low doses of somatostatin analog in the development and remission of type 1 diabetes mellitus in adult patients].
    Dvoráková H; Vondra K; Voborská M; Bendlová B; Kvapil M; Zamrazil V
    Vnitr Lek; 1998 Apr; 44(4):227-31. PubMed ID: 9820108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
    Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
    Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.